(All fields required)
Please enter a valid email.
Please enter your name.
Richard G. Azizkhan, MD Surgeon-in-Chief; Lester W. Martin Chair of Pediatric Surgery
does clinical trials and studies in patients with complex vascular anomalies and epidermolysis bullosa.
Surgeon-in-Chief; Lester W. Martin Chair of Pediatric Surgery
Surgical Director Emeritus, Hemangioma and Vascular Malformation Program
Professor, UC Department of Surgery
Complex mediastinal airway disorders; surgical oncology; neonatal anomalies; chest wall deformities; vascular malformations; esophageal disorders; pediatric trauma; epidermolysis bullosa
Trauma systems; injury prevention; fetal lung development; vascular malformations; solid tumors in childhood
Dr. Richard Azizkhan is the founding director of the Hemangioma and Vascular Malformations Center and established the Vascular Anomalies Training Fellowship. Due to his vision for an interdisciplinary and coordinated effort to treat children with vascular anomalies, he recruited outstanding professionals from multiple disciplines to be part of HVMC team. He has over 30 years of surgical experience in treating children with complex vascular anomalies. He is the Surgeon-in-Chief at Cincinnati Children’s Hospital Medical Center, is the first occupant of the Lester W. Martin Chair of pediatric surgery, and is a professor of surgery and pediatrics at the University Of Cincinnati College Of Medicine.
Dr. Azizkhan obtained his medical degree from the Milton S. Hershey Center of Pennsylvania State University College of Medicine, completed his pediatric surgery residency at Johns Hopkins and his research fellowship at Harvard with Dr. Judah Folkman. He has published extensively and is author of more than 200 papers and chapters, and five books.
As an international advocate for children’s rights and health, Dr. Azizkhan has made significant clinical and basic research contributions in angiogenesis and vascular malformations, lung development, airway reconstruction, solid tumors, trauma and injury prevention. Dr. Azizkhan has served in leadership roles in numerous national and international surgical organizations including the American Academy of Pediatrics Surgical Section, American Pediatric Surgical Association, and the American College of Surgeons. He is the President of the World Federation of Associations of Pediatric Surgeons (WOFAPS) and has been active in establishing international medical education exchange programs and medical humanitarian activities in Central Europe, the Middle East, Latin America, Asia and Africa. He was awarded an Honorary PhD from Tuzla University in 2001 and honorary citizenship of Tuzla in 2006 for his continuing contributions to improving the health system in Bosnia and all of the former Yugoslavian republics. Dr. Azizkhan also received the Ghandi Gold medal in 2005 from the Indian Association of Pediatric Surgeons for his global impact.
MD: Doctor of Medicine, Milton S. Hershey Center of Pennsylvania State University College of Medicine Hershey, PA, 1972 to 1975.
Residency: Pediatric Surgery, Johns Hopkins Hospital, Baltimore, MD; Surgery, University of Virginia Medical Center, Charlottesville, VA.
Fellowship: Department of Surgery, Children's Hospital Medical Center, Harvard Medical School, Boston, MA.
Certification: General Surgery, 1984, recertified 1992; Pediatric Surgery, 1986, recertified 1993; Surgical Critical Care, 1989.
Daniel von Allmen, MD Director, Division of General and Thoracic Surgery
Director, Division of General and Thoracic Surgery
Pediatric surgical oncology; pediatric inflammatory bowel disease; surgical innovation; surgical robotics
Oncology; innovation; surgical workforce
Daniel von Allmen, MD, comes to Cincinnati from Chapel Hill, NC where he was the surgeon-in-chief and division chief at the North Carolina Children’s Hospital.
Dr. von Allmen completed his general surgery training at the University of Cincinnati and Cincinnati Children’s Hospital Medical Center. He is currently the Program Committee chair of the American Pediatric Surgical Association. He also serves on the Program Committee for the American Academy of Pediatrics Surgical Section and is a member of the Steering Committee for the Surgical Section of the Children’s Oncology Group.
Dr. von Allmen's special clinical interests include pediatric surgical oncology, pediatric inflammatory bowel disease, surgical innovation, and surgical robotics.
Mayer ML, Beil HA, von Allmen D. Distance to care and relative supply among pediatric surgical subspecialties. J Pediatr Surg. 2009;44:483-495.
Maria H. Alonso-Peclet, MD Surgical Director, Kidney Transplant Program
Surgical Director, Kidney Transplant Program
Co-Surgical Director, Intestinal Transplant Surgery
Associate Professor, UC Department of Surgery
MD: University of Pennsylvania School of Medicine, Philadelphia, PA, 1982.
Residency: Surgery, Eastern Virginia Graduate School of Medicine, Norfolk, VA.
Fellowship: Trauma / Critical Care, Maryland Institute for Emergency Medical Services Systems, Baltimore, MD; Trauma / Burn, Children's National Medical Center, Washington, D.C.; Pediatric Surgery, Children's Mercy Hospital, Kansas City, MO; Transplantation, University of Cincinnati College of Medicine, Cincinnati, OH.
Certification: Surgery, 1999; Pediatric Surgery, 2001; Surgical Critical Care, 2001.
Rebeccah L. Brown, MD Associate Director, Trauma Services
Associate Director, Trauma Services
General pediatric surgery; trauma; injury prevention; minimally invasive surgery; necrotizing enterocolitis; neonatal surgery; minimally invasive surgery; congenital hemolytic anemias; chest wall deformities
Rebeccah L. Brown, MD, received a Bachelor of Science in biology and Bachelor of Arts in chemistry at New Mexico State University in Las Cruces, NM, in 1986. She graduated from University of New Mexico School of Medicine in Albuquerque, NM, with an MD in 1990. She completed her general surgery residency at University of Cincinnati Medical Center, in Cincinnati, Ohio, in 1997.
During her general surgical training, she also performed two years of basic science and clinical research in burn injuries and wound healing at the Shriners Hospitals for Children -- Cincinnati. She also served as an extracorporeal membrane oxygenation (ECMO) fellow at Cincinnati Children's Hospital Medical Center.
After completion of general surgery training, Dr. Brown completed a two-year fellowship in pediatric surgery at Children's Hospital of Buffalo in Buffalo, NY. She returned to Cincinnati Children's, Ohio, as assistant professor of surgery and pediatrics. Her main research interest is trauma and injury prevention, and she is currently the assistant director of Trauma Services, the fellowship director for the Pediatric Trauma Fellowship, and the director and cofounder of the Buckle Up for Life or Abrochate a la Vida program funded by Toyota.
Dr. Brown's clinical interests besides trauma and injury prevention include general pediatric surgery, minimally invasive surgery, inflammatory bowel disease, and Hirschsprung's disease.
Dr. Brown is a member of multiple professional organizations including the American College of Surgeons, American Medical Association, American Medical Women's Association, American College of Surgeons -- Ohio Chapter, Cincinnati Pediatric Society, Mont Reid Surgical Society, American Pediatric Surgical Association, American Academy of Pediatrics - Surgical Section and Injury Prevention Section, Eastern Association for the Surgery and Trauma, and Pediatric Trauma Society.
MD: University of New Mexico School of Medicine, Albuquerque, N.M., 1990.
Residency: General Surgery, University of Cincinnati Hospital, Cincinnati, OH, 1997.
Fellowship: Shriners Burns Institute, Cincinnati, Ohio, 1992-1994; ECMO, Children's Hospital Medical Center, Cincinnati, Ohio, 1993-1994; Pediatric Surgery Fellow, Children's Hospital of Buffalo, Buffalo, NY, 1997-1999.
Certification: Board-certified General Surgery, 1998, 2007; board-certified, Pediatric Surgery, 2000, 2009.
A. Roshni Dasgupta, MD, MPH Pediatric Surgeon, Division of Pediatric General and Thoracic Surgery
Pediatric Surgeon, Division of Pediatric General and Thoracic Surgery
Surgical oncology and vascular malformations; minimally invasive surgery; general pediatric surgery
Oncology and vascular malformations
Roshni Dasgupta, MD, MPH, is a surgeon and associate professor with the Hemangioma and Vascular Malformations Center. She has been involved with the HVMC team for the past eight years. Dr. Dasgupta obtained her medical degree at the University of Toronto. She finished her residency at Massachusetts General Hospital at Harvard Medical School. She completed a Rhodes Scholarship at the University of Oxford in Oxford England, followed by a Pediatric Surgery Fellowship at the Hospital for Sick Children in Toronto, Canada. She has also completed her Master of Public Health at the Harvard School of Public Health.
Dr. Dasgupta has authored multiple articles and book chapters on vascular anomalies and will be the next editor of the vascular anomalies edition of Seminars in Pediatric Surgery. She is interested in post-surgical long term outcomes of patients with vascular anomalies, as well as treatment and outcomes of hemangioma patients.
MD: University of Toronto, Toronto Canada, 1996.
Residency: Massachusetts General Hospital, Harvard Medical School 1996.-2003
Research Fellowship: University of Oxford, Oxford, England.
Fellowship: Hospital for Sick Children, Toronto, Canada.
MPH: Harvard School of Public Health, Boston, MA, 2009.
Hamilton TE, Barnhart D, Gow K, Ferrer F, Kandel J, Glick R, Dasgupta R, Naranjo A, He Y, Gratias E, Geller J, Ehrlich P. Inter-rater reliability of surgical reviews for AREN03B2: A COG renal tumor committee study. J Pediatr Surg. 2014 Jan;49(1):154-8.
Drolet BA, Trenor CC 3, Brandão LR, Chiu YE, Chun RH, Dasgupta R, Garzon MC, Hammill AM, Johnson CM, Tlougan B, Blei F, David M, Elluru R, Frieden IJ, Friedlander SF, Iacobas I, Jensen JN, King DM, Lee MT, Nelson S, Patel M, Pope E, Powell J, Seefeldt M, Siegel DH, Kelly M, Adams DM. Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma. J Pediatr. 2013 Jul;163(1):285-91.
Burke ME, Lyden ER, Meza, JL, Ladas EJ, Dasgupta R, Wiegner EA, Arndt CA. Does body mass index at diagnosis or weight change during therapy predict toxicity or survival in intermediate risk rhabdomyosarcoma? A report from the Children’s Oncology Group Soft Tissue Sarcoma Committee. Pediatr Blood Cancer. 2013 May;60(5):748-53.
Murrell Z, Dasgupta R. What predicts the risk of recurrent lung metastases? J Pediatr Surg. 2013 May;48(5):1020-4.
Chen W, Gupta A, Adams D, Patel M, Dasgupta R. Generalized lymphatic malformation with chylothorax: long-term management of a highly morbid condition in a pediatric patient. J Pediatr Surg. 2013 Mar;48(3):e9-e12.
Dasgupta R, Rodeberg DA. Update on rhabdomyosarcoma. Semin Pediatr Surg. 2012 Feb; 21(1):68-78.
Rymeski B, Burns K, Nagarajan R, Correll J, Kent D, O'Brien M, Perentesis JP, Dasgupta R. Long-term complications after staging laparotomy for Hodgkin lymphoma. J Clin Oncol 30, 2012.
Richard A. Falcone Jr., MD, MPH Director, Trauma Services
Director, Trauma Services
Pediatric injury prevention and outcomes; trauma education; management of colorectal disorders; inflammatory bowel disease; minimally invasive surgery; surgical oncology; extracorporeal life support (ECLS)
Nance ML, Krummel TM, Oldham KT, Falcone R JR, Trauma Committee of the American Pediatric Surgical Association. Firearm injuries and Children: A Policy Statement of the American Pediatric Surgical Association. J Am Coll Surg. 2013 Nov; 217(5): 940-6.
Patterson M, Geis G, Falcone R, LeMaster T, Wears R. In situ simulation: detection of safety threats and teamwork training in a high risk emergency department. BMJ Qual Saf. 2013 Jun;22(6):468-77.
Jurickova I, Collins MH, Chalk C, Seese A, Bezold R, Lake K, von Allmen D, Frischer JS, Falcone RA, Trapnell BC, Denson LA. Paediatric Crohn disease patients with stricturing behaviour exhibit ileal granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibody production and reduced neutrophil bacterial killing and GM-CSF bioactivity. Clin Exp Immunol. 2013 Jun;172(3)455-65.
Beaudin M, Maugans T, St-Vil D, Falcone RA Jr. Inappropriate use of infant seating devices increases risks of injury. J Pediatr Surg. 2013 May;48(5):1071-6.
Cook R, Gillespie GL, Kronk, R, Daugherty M, Moody SM, Allen LJ, Shebesta KB, Falcone RA. Effect of an Educational Intervention on Nursing Staff Knowledge, Confidence, and Practice in the Care of Children with Mild Traumatic Brain Injury. J Neurosci Nurs. 2013 Apr;45(2):108-18.
Kelleher DC, Renaud EJ, Ehrlich PF, Burd RS; Pediatric Trauma Society Guidelines Committee. Guidelines for alcohol screening in adolescent trauma patients: a report from the Pediatric Trauma Society Guidelines Committee. J Trauma Acute Care Surg. 2013 Feb;74(2):671-82.
Daugherty MC, Mehlman CT, Moody S, LeMaster T, Falcone RA Jr . Significant rate of misuse of the Hare traction splint for children with femoral shaft fractures. J Emerg Nurs. 2013 Jan;39(1):97-103.
Chatoorgoon K, Brown RL, Garcia VF, Falcone RA. Role of computed tomography and clinical findings in pediatric blunt intestinal injury: a multi-center study. Pediatr Emerg Care. 2012 Dec;28(12):1338-42.
Beaudin M, Daugherty M, Geis G, Moody S, Brown RL, Garcia VF, Falcone RA Jr. Assessment of factors associated with the delayed transfer of pediatric trauma patients: an emergency physician survey. Pediatr Emerg Care. 2012 Aug;28(8):758-63.
Falcone RA Jr, Haas L, King E, Moody S, Crow J, Moss A, Gaines B, McKenna C, Gourlay DM, Werner C, Meagher DP Jr, Schwing L, Garcia N, Brown D, Groner JI, Haley K, Deross A, Cizmar L, Armola R. A multicenter prospective analysis of pediatric trauma activation criteria routinely used in addition to the six criteria of the American College of Surgeons. J Trauma Acute Care Surg. 2012 Aug;73(2):377-84.
Jason S. Frischer, MD Director, Peña Colorectal Center
is a pediatric surgeon who has matched his clinical interest in inflammatory bowel disease (IBD) with his basic and translational research programs. He is investigating angiogenesis, or the development of blood vessels in IBD (Crohn’s disease and ulcerative colitis), and how it relates to inflammation and healing. He also has interests in ECMO, CDH and anticoagulation outcomes research.
Director, Peña Colorectal Center
Director, Extracorporeal Membrane Oxygenation (ECMO) Program
Division of Pediatric General and Thoracic Surgery
Assistant Professor, UC Department of Surgery
Chernoguz A, Crawford, K, Vandersall A, Willson T, Denson LA, Frischer JS. Pre-treatment with Anti-VEGF therapy may exacerbate inflammation in experimental acute colitis. J Pediatr Surg. 2012 Feb;47(2):347-54.
Le LD, Keswani SG, Biesiada J, Lim FY, Kingma PS, Haberman BE, Frischer J, Habli M, Crombleholme TM. The congenital diaphragmatic hernia composite prognostic index correlates with survival in left-sided congenital diaphragmatic hernia. J Pediatr Surg. 2012 Jan;47(1):57-62.
Lawal TA, Falcone RA, von Allmen D, Denson LA, Levitt MA, Warner BW, Frischer JS. The utility of routine pouchogram before ileostomy reversal in children and adolescents following ileal pouch anal anastomosis. J Pediatr Surg. 2011 Jun;46(6):1222-5.
Chernoguz A, Crawford KM, Donovan EC, Vandersall AE, Berglund C, Cripe TP, Frischer JS. EGFR Inhibition Fails to Suppress Vascular Proliferation and Tumor Growth in a Ewing’s Sarcoma Model. J Surg Res. 2012 Mar;173(1):1-9.
Lawal TA, Frischer JS, Falcone RA, Chatoorgoon K, Denson LA, Levitt MA. The transanal approach with laparoscopy or laparotomy for the treatment of rectal strictures in Crohn’s disease. J Laparoendosc Adv Surg Tech A. 2010 Nov;20(9):791-5.
Bischoff A, Gupta A, D’Mello S, Mezoff A, Podberesky D, Barnett S, Keswani S, Frischer JS. Crohn’s disease limited to the appendix: a case report in a pediatric patient. Pediatr Surg Int. 2010 Nov;26(11):1125-8.
Vuletin JF, Lim FY, Cnota J, Kline-Fath B, Salisbury S, Haberman B, Kingma P, Frischer JS, Crombleholme T. Prenatal pulmonary hypertension index: novel prenatal predictor of severe postnatal pulmonary artery hypertension in antenatally diagnosed congenital diaphragmatic hernia. J Pediatr Surg. 2010 Apr;45(4):703-8.
Frischer JS, Lee A, Serur A, Huang J, Bae JO, Kornfield ZN, Eljuga L, Shawber CJ, Feirt N, Mansukhani M, Stempak D, Baruchel S, Bender JG, Kandel JJ, Yamashiro DJ. Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling. Cancer Res. 2006 Apr;66(8):4378-84.
Frischer JS, Huang J, Serur A, Kadenhe-Chiweshe A, McCrudden KW, O’Toole K, Holash J, Yancopoulos GD, Yamashiro DJ, Kandel JJ. Effects of potent VEGF blockade on experimental Wilms tumor and its persisting vasculature. Int J Onc. 2004 Sep;25(3):549-53.
Huang J, Frischer JS, Serur A, Kadenhe A, Yokoi A, McCrudden KW, New T, O’Toole K, Zabski S, Rudge JS, Holash J, Yancopoulos GD, Yamashiro DJ, Kandel JJ. Regression of established tumors and metastases by potent vascular endothelial growth factor blockade. Proc Natl Acad Sci USA. 2003 June 24;100(13):7785-90.
Victor F. Garcia, MD, FACS, FAAP Founding Director, Trauma Services
Founding Director, Trauma Services
Pediatric injury research and control; chest-wall deformities; minimally invasive surgery (use of the laparoscope and thoracoscope to diagnose and treat surgical diseases); surgical weight loss; minority health care
Victor Garcia, MD, graduated from West Point, the University of Pennsylvania School of Medicine, studied pediatric surgery under C Everett Koop, and was Walter Reed’s chief of General/Pediatric Surgery.
Vic founded Children’s Trauma Center and led the effort to establish the country’s first Pediatric Weight Loss Surgery Center.
For his ongoing work to eliminate childhood health and social disparities, he has received numerous awards and commendations to include the Martin Luther King Humanitarian Award and the National Jefferson Award.
Vic has an uncompromising belief in the power of systems thinking and stakeholder engagement to solve society’s most intractable problems.
BS: Engineering, United States Military Academy, 1964-1968.
MD: University of Pennsylvania, School of Medicine, Philadelphia, PA, 1974.Residency: Walter Reed Army Medical Center, Washington, DC, 1978. Fellowship: Children's Hospital of Philadelphia, Philadelphia, PA. Certification: Surgery, 1979; Pediatric Surgery, 1982; Surgical Critical Care, 1991.
Chatoorgoon K, Brown RL, Garcia VF, Falcone, RA. Role of Computed Tomography and Clinical Findings in Pediatric Blunt Intestinal Injury. Pediatric Emergency Care. 2012;28 (12): 1338-1342.
Beaudin M, Daugherty M, Geis G, Moody S, Brown RL, Garcia VF, Falcone RA. Assessment of Factors Associated with the Delayed Transfer of Pediatric Trauma Patients. Pediatric Emergency Care. 2012;28 (8): 758-63.
Goldberg J, McClaine RJ, Cook B, Garcia VF, Brown RL, Crone K, Falcone RA. Use of a mild traumatic brain injury guideline to reduce inpatient hospital imaging and charges. Journal of Pediatric Surgery. 2011;46: 1777-1783.
McClaine RJ, Garcia VF. Unnatural Causes: Social Determinants of Child Health and Well-being. The Pediatric Forum, American Medical Association. 2011;165 (5): 476.
Chatoorgoon K, Huezo K, Rangel E, Francios N, Schweer L, Daugherty M, Koehn M, Richetts C, Brown RL, Garcia VF, Falcone RA. Unnecessary Imaging, Not Hospital Distance, or Transportation Mode Impacts Delays in the Transfer of Injured Children. Pediatric Emergency Care. 2010;26 (7): 481-486.
Martin CA, Care M, Rangel EL, Brown RL, Garcia VF, Falcone RA. Severity of head computed tomography scan findings fail to explain racial differences in mortality following child abuse. American Journal of Surgery. 2010;199 (2): 210-215.
Ippisch HM, Inge TH, Daniels SR, Wang B, Khoury PR, Witt SA, Glascock BJ, Garcia VF, Kimball TR. Reversibility of Cardiac Abnormalities in Morbidly Obese Adolescents. Journal of the American College of Cardiology. 2008;51(14): 1342-1348.
Falcone RA , Martin C, Brown RL, Garcia VF. Despite overall low pediatric head injury mortality, disparities exist between races. Journal of Pediatric Surgery. 2008;43(10), 1858-1864.
Falcone RA, Daugherty M, Schweer L, Patterson M, Brown RL, Garcia VF. Multidisciplinary pediatric trauma team training using high-fidelity trauma simulation. Journal of Pediatric Surgery. 2008;43(6), 1065-1071.
Rangel SJ, Martin CA, Brown RL, Garcia VF, Falcone RA. Alarming trends in the improper use of motor vehicle restraints in children: implications for public policy and the development of race-based strategies for improving compliance. Journal of Pediatric Surgery. 2008;43(1), 200-207.
Mounira A. Habli, MD Maternal Fetal Medicine Specialist, Cincinnati Fetal Center
Maternal Fetal Medicine Specialist, Cincinnati Fetal Center
Modification of the Wigglesworth model of Intrauterine growth restriction in mice as the animal model; invitro assessment of Insulin like growth factors and adenoviral associated gene expression of insulin like growth factor-I in a rat trophoblast cell line (RCHO-1).
Visit the Habli Lab.
Michael A. Helmrath, MD, MS Surgical Director, Intestinal Rehabilitation Program
Surgical Director, Intestinal Rehabilitation Program
Director of Surgical Research
Pediatric Surgeon, Peña Colorectal Center
As a pediatric surgeon, Dr. Helmrath has dedicated his career to the care of patients with intestinal failure. The main focus of his laboratory is directed towards characterizing intestinal stem cells during intestinal adaptation and developing intestinal regenerative strategies. By combining his clinical experience as the surgical director of intestinal research and rehabilitation at Cincinnati Children’s, his long-term goal is to establish translational therapies for the management of patients with short bowel syndrome.
BA: Miami University, Oxford, OH, 1987.
MD: University of Cincinnati College of Medicine, Cincinnati, OH, 1993.MS: University of Cincinnati College of Medicine, Cincinnati, OH, 1989.
Certification: Board-certified General Surgery; board-certified, Pediatric Surgery.
Michalsky MP, Inge TH, Teich S, Eneli I, Miller R, Brandt ML, Helmrath M, Harmon CM, Zeller MH, Jenkins TM, Courcoulas A, Buncher RC; Teen-LABS Consortium. Adolescent bariatric surgery program characteristics: The Teen Longitudinal Assessment of Bariatric Surgery (Teen-LABS) study experience. Semin Pediatr Surg. 2014 Feb;23(1):5-10.
Inge TH, Zeller MH, Jenkins TM, Helmrath M, Brandt ML, Michalsky MP, Harmon CM, Courcoulas A, Horlick M, Xanthakos SA, Dolan L, Mitsnefes M, Barnett SJ, Buncher R; Teen-LABS Consortium. Perioperative outcomes of adolescents undergoing bariatric surgery: the Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) study. JAMA Pediatr. 2014 Jan;168(1):47-53.
Ubesie AC, Kocoshis SA, Mezoff AG, Henderson CJ, Helmrath MA, Cole CR. Multiple micronutrient deficiencies among patients with intestinal failure during and after transition to enteral nutrition. J Pediatr. 2013 Dec;163(6):1692-6.
Eradi B, Hamrick M, Bischoff A, Frischer JS, Helmrath M, Hall J, Pena A, Levitt MA. The role of a colon resection in combination with a Malone appendicostomy as part of a bowel management program for the treatment of fecal incontinence. J Pediatr Surg. 2013 Nov; 48(11):2296-300.
Fuller MK, Faulk DM, Sundaram N, Mahe MM, Stout KM, von Furstenberg RJ, Smith BJ, McNaughton KK, Shroyer NF, Helmrath MA, Henning SJ. Intestinal stem cells remain viable after prolonged tissue storage. Cell Tissue Res. 2013 Nov;354(2):441-50.
Devine AA, Gonzalez A, Speck KE, Knight R, Helmrath M, Lund PK, Azcarate-Peril MA. Impact of ileocecal resection and concomitant antibiotics on the microbiome of the murine jejunum and colon. PLoS One. 2013; 8(8):e73140.
Fuller MK, Faulk DM, Sundaram N, Shroyer NF, Henning SJ, Helmrath MA. Intestinal crypts reproducibly expand in culture. J Surg Res. 2012 Nov;178(1):48-54.
Stelzner M, Helmrath M, Dunn JC, Henning SJ, Houchen CW, Kuo C, Lynch J, Li L, Magness ST, Martin MG, Wong MH, Yu J; NIH Intestinal Stem Cell Consortium. A nomenclature for intestinal in vitro cultures. Am J Physiol Gastrointest Liver Physiol. 2012 Jun 15;302(12):G1359-63.
Van Landeghem L, Blue RE, Dehmer JJ, Henning SJ, Helmrath MA, Lund PK. Localized intestinal radiation and liquid diet enhance survival and permit evaluation of long-term intestinal responses to high dose radiation in mice. PLoS One. 2012;7(12):e51310.
Adolescent Bariatrics: Assessing Health Benefits & Risk. Co-investigator. National Institute of Diabetes and Digestive and Kidney Diseases. Nov 2011 – Oct 2016. U01 DK072493.
Human Endocrine Cell Development. Co-investigator. National Institute of Diabetes and Digestive and Kidney Diseases. Apr 2012 – Mar 2017. R01 DK092456.
Belinda Hsi Dickie, MD, PhD Pediatric Surgeon, Peña Colorectal Center
is a pediatric surgeon who has a basic science lab in vascular biology. Her lab is focusing on the pathways of lymphangiogenesis and the genetics involved in the development of vascular malformations.
513-636 3240 firstname.lastname@example.org
Surgical Director, Hemangioma and Vascular Malformation Program
Assistant Professor, UC Department of Pediatrics
Phone 513-636 3240
Colorectal surgery; vascular malformations; minimally invasive surgery; general pediatric surgery
Belinda Hsi Dickie, MD, PhD, is the surgical director of the Hemangioma and Vascular Malformations Center since July 2013. She is also the director of the Vascular Anomalies Fellowship. Dr. Dickie is an assistant professor with the Division of Pediatric General and Thoracic Surgery at Cincinnati Children's Hospital Medical Center. She obtained her medical degree at the University of Toronto, and completed general surgery residency and an advanced minimally invasive surgery fellowship at the University of Alberta. She continued her training, completing fellowships in pediatric vascular malformations and pediatric colorectal surgery at Cincinnati Children’s Hospital Medical Center and in pediatric surgery at the University of Florida. She returned to Cincinnati Children’s in 2011.
Dr. Dickie has a special interest in the medical and surgical treatment of vascular malformations, and minimally invasive surgery. She has a lab in vascular biology which looks at the genetics and molecular pathways involved with lymphangiogenesis, and the genetics involved in the development of vascular malformations. The lab is looking at novel mutations in vascular malformations and the potential effects on lymphatic growth, and different treatment alternatives.
MD: University of Toronto, Toronto,Ontario, Canada 1998.Residency: General Surgery, University of Alberta, Edmonton, Alberta, Canada.Fellowship: Advanced Minimally Invasive Surgery, University of Alberta, Edmonton, Alberta, Canada; Vascular anomalies, Cincinnati Children's, Cincinnati, OH; Pediatric Colorectal Surgery, Cincinnati Children's, Cincinnati, OH; Pediatric Surgery, University of Florida Gainesville, Florida.Certification: General Surgery, 2006; Pediatric Surgery, 2011.
Dickie BH, Webb KM, Eradi B, Levitt MA. The problematic Soave cuff in Hirschsprung disease: Manifestations and treatment. J Pediatr Surg. 2014 Jan;49(1):77-81.
Knod JL, Garrison AP, Frischer JS, Dickie B. Foregut duplication cyst associated with esophageal atresia and tracheoesophageal fistula: a case report and literature review. J Pediatr Surg. 2013 May;48(5):E5-7.
de Blaauw I, Midrio P, Breech L, Bischoff A, Dickie B, Versteegh HP, Peña A, Levitt MA. Treatment of adults with unrecognized or inadequately repaired anorectal malformations: 17 cases of rectovestibular and rectoperineal fistulas. J Pediatr Adolesc Gynecol. 2013 Jun;26(3):156-60.
Levitt MA, Dickie B, Peña A. The Hirschsprungs patient who is soiling after what was considered a "successful" pull-through. Semin Pediatr Surg. 2012 Nov;21(4):344-53.
Murrell Z, Dickie B, Dasgupta R. Lung nodules in pediatric oncology patients: a prediction rule for when to biopsy. J Pediatr Surg. 2011 May;46(5):833-7.
Cuenca AG, Reddy SV, Dickie B, Kays DW, Islam S. The usefulness of the upper gastrointestinal series in the pediatric patient before anti-reflux procedure or gastrostomy tube placement. J Surg Res. 2011 Oct;170(2):247-52.
Levitt MA, Dickie B, Peña A. Evaluation and treatment of the patient with Hirschsprung disease who is not doing well after a pull-through procedure. Semin Pediatr Surg. 2010 May;19(2):146-53.
Dickie B, Dasgupta R, Nair R, Alonso MH, Ryckman FC, Tiao GM, Adams DM, Azizkhan RG. Spectrum of hepatic hemangiomas: management and outcome. J Pediatr Surg. 2009 Jan;44(1):125-33.
Kneteman NM, Weiner AJ, O'Connell J, Collett M, Gao T, Aukerman L, Kovelsky R, Ni ZJ, Zhu Q, Hashash A, Kline J, Hsi B, Schiller D, Douglas D, Tyrrell DL, Mercer DF. Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application. Hepatology. 2006 Jun;43(6):1346-53. Hao C, Song JH, Hsi B, Lewis J, Song DK, Petruk KC, Tyrrell DL, Kneteman NM. TRAIL inhibits tumor growth but is nontoxic to human hepatocytes in chimeric mice. Cancer Res. 2004 Dec 1;64(23):8502-6.
Thomas H. Inge, MD, PhD, FACS, FAAP Surgical Director, Surgical Weight Loss Program for Teens
Surgical Director, Surgical Weight Loss Program for Teens
Director, Center for Bariatric Research and Innovation
Attending Surgeon, Cincinnati Children’s Hospital Medical Center
Thomas H. Inge, MD, PhD, is a Virginia native who grew up in a rural, farming community in Dinwiddie County. He received his BS in biology at the College of William and Mary in Williamsburg, VA, in 1987. Dr. Inge entered the Medical College of Virginia in Richmond, VA, in the Medical Scientist Training Program, and pursued degrees in microbiology/immunology and medicine. He graduated with MD and PhD degrees in 1993.
Dr. Inge received his surgical training at Stanford University Hospital in Palo Alto, CA, where he developed an interest in pediatric surgery. At the completion of his chief resident year in 1998, he moved to Birmingham, AL, for specialty training in pediatric surgery at the Children's Hospital of Alabama, with an emphasis on pediatric minimally invasive surgery. Dr. Inge became a full-time member of the surgical staff at Cincinnati Children's Hospital Medical Center and faculty member of the University of Cincinnati College of Medicine, Department of Surgery, Division of Pediatric Surgery, in July 2000.
In addition to general pediatric surgical practice, Dr. Inge's clinical research focus is related to bariatric surgery in adolescents. He is the surgical director of the Surgical Weight Loss Program for Teens, offering surgery for overweight adolescents with complications from their excess weight. He has served as a consultant to the Food and Drug Administration for projects related to device treatment of pediatric obesity. He is also the Principal Investigator of two research projects funded by National Institutes of Health (NIH) and co-investigator of another NIH funded project examining the role of surgery for management of adolescent obesity. He currently serves as Study Chairman of Teen-LABS, a multicenter research consortium examining outcomes of adolescent bariatric surgery.
Dr. Inge has given over 50 invited lectures nationally and internationally over the past four years, has mentored more than a dozen fellows and students, and has authored more than 70 published chapters and manuscripts.
BS: College of William and Mary, Williamsburg, VA, 1987.MD: Medical College of Virginia, Virginia Commonwealth University, Richmond, VA, 1993.PhD: Virginia Commonwealth University, Richmond, VA, 1993.Residency: Stanford University Hospital, Stanford, CA, 1998.
Fellowship: Children's Hospital of Alabama, Birmingham, AL, 2000.
Board Certification: Diplomate of the American Board of Surgery, December 1999; Certification in Pediatric Surgery, American Board of Surgery, March 2002.
Zeller MH, Jenkins TM, Helmrath M, Brandt ML, Michalsky MP, Harmon CM,
Courcoulas A, Horlick M, Xanthakos SA, Dolan L, Mitsnefes M, Barnett SJ,
Buncher R, for the Teen-LABS Consortium. Perioperative Outcomes of Adolescents
Undergoing Bariatric Surgery: The Teen-Longitudinal Assessment of Bariatric
Surgery (Teen-LABS) Study. JAMA Pediatr. 2014 Jan;168(1):47-53; PubMed PMID:
M, Boillot A, Muzard L, Poitou C, Oppert JM, Barsamian C, Gatta B, Müller H,
Weismann D, Rottembourg D, Inge T, Veyrie N, Carette C, Czernichow S. Bariatric surgery following treatment for
craniopharyngioma: a systematic review and individual-level data meta-analysis.
J Clin Endocrinol Metab. 2013 Mar 26. [Epub ahead of print] PubMed PMID:
Kelly AS, Barlow SE, Rao G, Inge TH, Hayman LL,
Steinberger J, Urbina EM, Ewing LJ, Daniels SR. Severe obesity in children and
adolescents: identification, associated health risks, and treatment approaches:
a scientific statement from the American Heart Association. Circulation. 2013
TH, King WC, Jenkins TM, Courcoulas AP, Mitsnefes M, Flum DR, Wolfe BM, Pomp A,
Dakin GF, Khandelwal S, Zeller MH, Horlick M, Pender JR, Chen JY, Daniels SR. The Effect of Obesity in Adolescence on Adult Health Status. Pediatrics. 2013
Dec;132(6):1098-104; PubMed PMID: 24249816.
D. Kaulfers, Judy A. Bean, Thomas H. Inge, Lawrence M. Dolan, Heidi J. Kalkwarf. Bone Loss in Adolescents after Bariatric
Surgery. Pediatrics. 2011;
127(4):e956-61. PMCID: PMC3065081.
TH, Jenkins TM, Zeller M, Dolan L, Daniels SR, Garcia VF, Brandt ML, Bean J,
Gamm K, Xanthakos SA. Baseline BMI is a strong predictor of nadir BMI after
adolescent gastric bypass. J Pediatr. 2010; 156(1):103. PMID 19775700.
Inge TH, Miyano G, Bean J, Helmrath
M, Courcoulas A, Harmon CM, Chen MK, Wilson K, Daniels SR, Garcia VF, Brandt
ML, Dolan LM. Reversal
of type 2 diabetes mellitus and improvements in cardiovascular risk factors
after surgical weight loss in adolescents. Pediatrics. 2009 Jan;123(1):214-22.
PubMed PMID: 19117885.
JS, Lenders CM, Dionne EA, Hoppin AG, Hsu GL, Inge TH, Lawlor DF, Marino MF,
Meyers AF, Rosenblum JL, Sanchez VM. Best practice updates for
pediatric/adolescent weight loss surgery. Obesity (Silver Spring). 2009
May;17(5):901-10. Feb 19.
M. Ippisch, Thomas H. Inge, Stephen R. Daniels, Baiyang Wang, Philip R. Khoury,
Sandra A. Witt, Betty J. Glascock, Victor F. Garcia, Thomas R. Kimball. Reversibility of Cardiac Abnormalities in Extremely Overweight
Adolescents. Journal of the American College of Cardiology 2008 Apr
WS, Inge TH, Burd RS. Bariatric surgery in adolescents: recent national trends
in use and in-hospital outcome. Archives
of Pediatric and Adolescent Medicine. 2007 Mar;161(3):217-21.
Helen N. Jones, PhD
is a placental physiologist who has research interests in placental function in pathological pregnancies and the development of non-viral mediated gene therapies in fetal growth restriction. Her lab studies the underlying mechanisms of placental insufficiency and potential therapies leading to increased placental function and fetal growth.
Visit the Jones Lab.
Regulation of placental growth and function; regulation of mechanisms of placental nutrient transfer and consequences for fetal growth
Wang K, Dong HQ, Zhao ZL, Li YY, Li C, Jones HN, Shi DL,Zhang XZ. Novel Vesicles Self-Assembled from Amphiphilic Star-Armed PEG-Polypeptide Hybrid Copolymers for Drug Delivery. Macromolecular Bioscience 2011;11:65-71.
Jones HN, Powell TL, Jansson T. Differential regulation of placental amino acid transport mechanisms by Adiponectin. Diabetes. 2010;59(5):1161-70.
Jones HN, Powell TL, Jansson T. IL-6 stimulates System A amino acid transporter activity in trophoblast cells through STAT3 and increased expression of SNAT2. Am J Physiol Cell Physiol. 2009;297(5):C1228-35.
Jones HN,Woollett LA, Barbour N, Prasad PD, Powell TL, Jansson T. High-fat diet before and during pregnancy causes marked up-regulation of placental nutrient transport and fetal overgrowth in C57/BL6 mice. FASEB J. 2009;23(1):271-8.
McArdle HJ, Andersen HS, Jones H, Gambling L. Copper and iron transport across the placenta: regulation and interactions. J Neuroendocrinol. 2008;20(4):427-31.
Jones HN, Powell TL, Jansson T. Regulation of Placental Nutrient Transport – A Review. Placenta. 2007;28l; 763- 774.
Ferguson-Smith AC, Moore T, Detmar J, Lewis A, Hemberger M, Jammes H, Kelsey G, Roberts CT, Jones H, Constancia M. Epigenetics and imprinting of the trophoblast -- a workshop report. Placenta. 2006;Suppl A:S122-6.
McArdle HJ, Andersen HS, Jones H, Gambling L. Fetal Programming: Causes and Consequences as Revealed by Studies of Dietary Manipulation in Rats – A Review. Placenta. 2006;27:56-60.
Jones HN, Ashworth CJ, Page KR, McArdle HJ. Cortisol stimulates System A amino acid transport and SNAT2 expression in a human placental cell line (BeWo). Am. J. Physiol Endocrinology and Metabolism. 2006;291(3):E596-603.
Jones HN, Ashworth CJ, Page KR, McArdle HJ. Expression and adaptive regulation of amino acid transport system A in a placental cell line under amino acid restriction. Reproduction. 131:951-60, 2006.
Sundeep G. Keswani, MD Pediatric Surgeon, Division of General, Thoracic and Fetal Surgery
has research interests in gene therapy applications, bone marrow contribution to tissue repair, and fetal diagnosis and treatment.
Visit the Keswani Lab.
Pediatric Surgeon, Division of General, Thoracic and Fetal Surgery
Fetal Surgeon, Cincinnati Fetal Center
Director, Pediatric Advanced Wound Care and Skin Services
Gene therapy applications; bone marrow contribution to tissue repair; fetal diagnosis and treatment.
Dr. Sundeep G. Keswani is a pediatric and fetal surgeon. He is also the director of the Pediatric Advanced Wound Care and Skin Service (PAWS), which is a state-of-the-art wound care center devoted to the care of children. Dr. Keswani is the lead principal investigator in the Cincinnati Children’s Wound Healing Research Group, which is an NIH-funded laboratory that focuses on understanding the molecular mechanisms which underlie the fetus’ ability to regeneratively heal wounds with the goal of developing novel therapeutics to achieve regenerative wound healing in postnatal tissue.
Alice King MD, Swathi Balaji PhD, Louis D. Le MD, Emily Marsh, Timothy M. Crombleholme MD, Sundeep G. Keswani MD. Interleukin-10 Regulates Fetal Extracellular Matrix Hyaluronan Production. Journal of Pediatric Surgery. (In press).
Visscher M, King A, Nie AM, Schaffer P, Taylor T, Pruitt D, Giaccone MJ, Ashby M, Keswani S. A Quality-Improvement Collaborative Project to Reduce Pressure Ulcers in PICUs. Pediatrics. 2013 Jun;131(6):e1950-60.
Keswani SG, Balaji S, Le LD, Leung A, Parvadia JK, Frischer J, Yamano S, Taichman N, Crombleholme TM. Role of salivary vascular endothelial growth factor (VEGF) in palatal mucosal wound healing. Wound Repair Regen. 2013 Jun 11.
King A, Balaji S, Marsh E, Le LD, Shaaban AF, Crombleholme TM, Keswani SG. Interleukin-10 regulates the fetal hyaluronan-rich extracellular matrix via a STAT3-dependent mechanism. J Surg Res. 2013 Apr 24.
Balaji S, King A, Dhamija Y, Le LD, Shaaban AF, Crombleholme TM, Keswani SG. Pseudotyped adeno-associated viral vectors for gene transfer in dermal fibroblasts: implications for wound-healing applications. J Surg Res. 2013 Apr 3.
Keswani SG, Balaji S, Le L, Leung A, Katz AB, Lim FY, Habli M, Jones HN, Wilson JM, Crombleholme TM. Pseudotyped AAV vector-mediated gene transfer in a human fetal trachea xenograft model: implications for in utero gene therapy for cystic fibrosis. PLoS One. 2012;7(8):e43633.
Keswani SG, Balaji S, Le L, Leung A, Lim FY, Habli M, Jones HN, Wilson JM, Crombleholme TM. Pseudotyped adeno-associated viral vector tropism and transduction efficiencies in murine wound healing. Wound Repair Regen. 2012 Jul-Aug;20(4):592-600.
Gordon A, Kozin ED, Keswani SG, Vaikunth SS, Katz AB, Zoltick PW, Favata M, Radu AP, Soslowsky LJ, Herlyn M, Crombleholme TM. Permissive environment in postnatal wounds induced by adenoviral-mediated overexpression of the anti-inflammatory cytokine interleukin-10 prevents scar formation. Wound Repair Regen. 2008 Jan-Feb;16(1):70-9.
Javazon EH, Keswani SG, Badillo AT, Crombleholme TM, Zoltick PW, Radu AP, Kozin ED, Beggs K, Malik AA, Flake AW. Enhanced epithelial gap closure and increased angiogenesis in wounds of diabetic mice treated with adult murine bone marrow stromal progenitor cells. Wound Repair Regen. 2007 May-Jun;15(3):350-9.
Keswani SG, Katz AB, Lim FY, Zoltick P, Radu A, Alaee D, Herlyn M, Crombleholme TM. Adenoviral mediated gene transfer of PDGF-B enhances wound healing in type I and type II diabetic wounds. Wound Repair Regen. 2004 Sep-Oct;12(5):497-504.
Foong-Yen Lim, MD Surgical Director, Cincinnati Fetal Center
Surgical Director, Cincinnati Fetal Center
Open fetal surgery and fetoscopic surgery; ex-utero intrapartum treatment (EXIT); congenital high airway obstruction syndrome (CHAOS); congenital diaphragmatic hernia (CDH); fetal gene therapy; neonatal surgery; thoracic surgery; minimally invasive surgery
Visit the Lim Lab.
Jaimie D. Nathan, MD Surgical Director, Intestinal Transplant Program
is a pediatric general, thoracic and transplant surgeon, who has a basic science research program in the role of the gut microbiome in the modulation of liver injury and cholangiopathies. His lab studies the gut-liver axis as it relates to the pathogenesis of a number of liver diseases which can progress to end-stage liver disease requiring transplantation.
Surgical Director, Intestinal Transplant Program
Surgical Director, Pancreas Care Center
UC Department of Pediatrics
Hepatobiliary and pancreatic disease; liver, kidney, and intestinal transplantation; pediatric surgical oncology; neonatal surgery; minimally invasive surgery
BS: Yale University, New Haven, CT, 1993.
MD: Yale University, New Haven, CT, 1998.
Residency: General Surgery, Duke University Medical Center, Durham, NC, 1998-2000 and 2002-2005.
Surgical Research Fellowship: Duke University Medical Center, Durham, NC, 2000-2002.
Pediatric Surgery Fellowship: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2005-2007.
Transplant Surgery Fellowship: University of Cincinnati, Cincinnati, OH, 2007-2009.
Certification: American Board of Surgery, General Surgery, 2007; American Board of Surgery, Pediatric Surgery, 2008; American Society of Transplant Surgeons Certification, 2009.
Prada CE, Kaul A, Hopkin RJ, Page KI, Nathan JD, Bartholomew DW, Cohen MB, Heubi JE, Leslie ND, Burrow TA. Recurrent pancreatitis in ornithine transcarbamylase deficiency. Mol Genet Metab. 2012 Aug;106(4):482-484.
Bondoc AJ, Taylor JA, Alonso MH, Nathan JD, Wang Y, Balistreri WF, Bezerra JA, Ryckman FC, Tiao GM. The beneficial impact of revision of Kasai portoenterostomy for biliary atresia: an institutional study. Ann Surg. 2012 Mar;255(3):570-576.
Shin CR, Nathan J, Alonso M, Yazigi N, Kocoshis S, Tiao G, Davies SM. Incidence of acute and chronic graft-versus-host disease and donor T-cell chimerism after small bowel or combined organ transplantation. J Pediatr Surg. 2011 Sep;46(9):1732-1738.
Vigna SR, Shahid RA, Nathan JD, McVey DC, Liddle RA. Leukotriene B4 mediates inflammation via TRPV1 in duct obstruction-induced pancreatitis in rats. Pancreas. 2011 Jul;40(5):708-714.
Nathan JD, Romac J, Peng RY, Peyton M, Rockey DC, Liddle RA. Protection against chronic pancreatitis and pancreatic fibrosis in mice overexpressing pancreatic secretory trypsin inhibitor. Pancreas. 2010 Jan;39(1):e24-30.
Ryckman FC, Bucuvalas JC, Nathan J, Alonso M, Tiao G, Balistreri WF. Outcomes following liver transplantation. Semin Pediatr Surg. 2008 May;17(2):123-30.
Follmar KE, Condron SA, Turner II, Nathan JD, Ludwig KA. Treatment of metronidazole-refractory Clostridium difficile enteritis with vancomycin. Surg Infect. 2008 9:195-200.
Nathan JD, Rudolph JA, Kocoshis SA, Alonso MH, Ryckman FC, Tiao GM. Isolated liver and multivisceral transplantation for total parenteral nutrition-related end-stage liver disease. J Pediatr Surg. 2007 Jan;42(1):143-7.
Patel MB, Nathan JD, Frush DP, Rice HE. Nonoperative management of asymptomatic traumatic pulmonary hernia in a young child. J Trauma. 2007 62:234-235.
Nathan JD, Romac J, Peng RY, Peyton M, MacDonald RJ, Liddle RA. Transgenic expression of pancreatic secretory trypsin inhibitor-I ameliorates secretagogue-induced pancreatitis in mice. Gastroenterology. 2005 128:717-727.
Jose L. Peiro, MD Endoscopic Fetal Surgery Director, Cincinnati Fetal Center
is in the cutting-edge of fetal myelomeningocele intrauterine repair innovation, allowing a fetoscopic approach for the treatment of this devastating condition, as well as looking for innovative strategies for treatment of CDH by means fetal tracheal occlusion.
Visit the Peiro Lab.
Endoscopic Fetal Surgery Director, Cincinnati Fetal Center
Pediatric Surgeon, Division of General and Thoracic Surgery
Neonatal surgery; fetal surgery
MD: Medical School at Universidad Autonoma de Barcelona, Barcelona, Spain, 1989.
MBA: Health and Hospital Management, Universitat Oberta de Catalunya (UOC), Barcelona, Spain, 2010-2012.
Residency: Pediatric Surgery, Hospital Vall Hebron (UAB), Barcelona, Spain, 1991-1995.
Observership: Fetal Surgery, The Children's Hospital of Philadelphia, Philadelphia, PA, 2001.
Burgos L, Encinas JL, García-Cabezas MA, Peiró JL, López-Santamaría M, Jaureguízar E. Bladder Changes After Several Coverage Modalities in the Surgically Induced Model of Myelomeningocele in Lambs. Actas Urol Esp. 2014 January - February;38(1):55-61.
Peiro JL, Fontecha CG, Ruano R, Esteves M, Fonseca C, Marotta M, Haeri S, Belfort MA. Single-Access Fetal Endoscopy (SAFE) for myelomeningocele in sheep model I: amniotic carbon dioxide gas approach. Surg Endosc. 2013 Oct;27(10):3835-40.
Ruano R, Peiro JL, da Silva MM, Campos JA, Carreras E, Tannuri U, Zugaib M. Early fetoscopic tracheal occlusion for extremely severe pulmonary hypoplasia in isolated congenital diaphragmatic hernia: preliminary results. Ultrasound Obstet Gynecol. 2013 Jul;42(1):70-6.
Peiró JL, Encinas JL. Fetal surgery of myelomeningocele: from experimental results to clinical evidence. Cir Pediatr. 2012 Jan;25(1):1-3.
Encinas JL, García-Cabezas MÁ, Barkovich J, Fontecha CG, Peiró JL, Soto GM, Borrell V, Reillo I, López-Santamaría M, Tovar JA, Farmer DL. Maldevelopment of the cerebral cortex in the surgically induced model of myelomeningocele: implications for fetal neurosurgery. J Pediatr Surg. 2011 Apr;46(4):713-22.
Fontecha CG, Peiro JL, Sevilla JJ, Aguirre M, Soldado F, Fresno L, Fonseca C, Chacaltana A, Martinez V. Fetoscopic coverage of experimental myelomeningocele in sheep using a patch with surgical sealant. Eur J Obstet Gynecol Reprod Biol. 2011 Jun;156(2):171-6.
Peiró JL, Carreras E, Guillén G, Arévalo S, Sánchez-Durán MA, Higueras T, Castillo F, Marhuenda C, Lloret J, Martínez-Ibáñez V. Therapeutic indications of fetoscopy: a 5-year institutional experience. J Laparoendosc Adv Surg Tech A. 2009 Apr;19(2):229-36.
Castillo F, Peiró JL, Carreras E, Ruiz C, Linde A, Ribes C, Creus A. The exit procedure (ex-utero intrapartum treatment): management of giant fetal cervical teratoma. J Perinat Med. 2007;35(6):553-5.
Alberto Peña, MD Founding Director, Peña Colorectal Center
Founding Director, Peña Colorectal Center
Colorectal pediatric surgery; clinical research regarding colorectal problems in children
Alberto Peña, MD, is the founding director of the Colorectal Center at Cincinnati Children's and clinical professor of surgery at the University of Cincinnati. He received his medical degree at the Military Medical School in Mexico City in 1962.
Dr. Peña trained in general surgery and medical pediatrics at the Central Military Hospital, finishing in 1968. From 1969 until December 1971, he trained at Boston Children's Hospital.
Dr. Peña moved back to Mexico City as the surgeon-in-chief of the National Institute of Pediatrics from January 1972 until June 1985.
In 1982, Dr. Peña described a new approach for the management of anorectal malformations: Posterior Sagittal Anoplasty / PSARP, also known as the Peña Pull-Through Procedure.
Dr. Peña joined the full-time staff at Schneider Children's Hospital in July 1985 and was the chief of Pediatric Surgery and professor of Surgery at the Albert Einstein College of Surgeons until July 2005.
Since 1982 until the present, Dr. Peña has been traveling all over the world, lecturing and operating on children affected by this particular malformation.
In July 2005 Dr. Peña moved to Cincinnati Children's and became the director of the first colorectal center for children in the world.
At the present time, Dr. Peña dedicates 80 percent of his time to the treatment of anorectal problems in children.
Seventy percent of the patients operated on by Dr. Peña at Cincinnati Children's come from other states and from all over the world.
Dr. Peña has published over 179 papers in national and international journals and has published 80 book chapters.
Bischoff A, Levitt MA, Breech L, Peña A. Covered cloacal exstrophy--a poorly recognized condition: hints for a correct diagnosis. J Pediatr Surg. 2013 Dec;48(12):2389-92.
Eradi B, Hamrick M, Bischoff A, Frischer JS, Helmrath M, Hall J, Peña A, Levitt MA. The role of a colon resection in combination with a Malone appendicostomy as part of a bowel management program for the treatment of fecal incontinence. J Pediatr Surg. 2013 Nov;48(11):2296-300.
Levitt MA, Hamrick MC, Eradi B, Bischoff A, Hall J, Peña A. Transanal, full-thickness, Swenson-like approach for Hirschsprung disease. J Pediatr Surg. 2013 Nov;48(11):2289-95.
Bischoff A, Levitt MA, Peña A. Update on the management of anorectal malformations. Pediatr Surg Int. 2013 Sep;29(9):899-904.
Brisighelli G, Bischoff A, Levitt M, Hall J, Monti E, Peña A. Coloboma and anorectal malformations: a rare association with important clinical implications. Pediatr Surg Int. 2013 Sep;29(9):905-12.
Bischoff A, Peña A, Levitt MA. Laparoscopic-assisted PSARP - the advantages of combining both techniques for the treatment of anorectal malformations with recto-bladderneck or high prostatic fistulas. J Pediatr Surg. 2013 Feb;48(2):367-71.
Bischoff A, Levitt MA, Breech L, Hall J, Peña A. Vaginal switch--a useful technical alternative to vaginal replacement for select cases of cloaca and urogenital sinus. J Pediatr Surg. 2013 Feb;48(2):363-6. Erratum in: J Pediatr Surg. 2013 Sep;48(9):1993.
Bischoff A, Calvo-Garcia MA, Baregamian N, Levitt MA, Lim FY, Hall J, Peña A. Prenatal counseling for cloaca and cloacal exstrophy-challenges faced by pediatric surgeons. Pediatr Surg Int. 2012 Aug;28(8):781-8.
Hamrick M, Eradi B, Bischoff A, Louden E, Peña A, Levitt M. Rectal atresia and stenosis: unique anorectal malformations. J Pediatr Surg. 2012 Jun;47(6):1280-4.
Frederick C. Ryckman, MD Professor of Surgery / Transplantation
Professor of Surgery / Transplantation
Sr. Vice President, Medical Operations
Transplantation; liver; kidney transplantation; small intestine; biliary disease; Extracorporeal membrane oxygenation (ECMO); minimally invasive surgery; chest wall abnormalities
Frederick C. Ryckman, MD, is clinical director of the Pediatric General and Thoracic Surgery Division.
Dr. Ryckman is also vice president of System Capacity & Perioperative Operations.
Dr. Ryckman is also a pediatric surgeon at the Cincinnati Fetal Center.
Wagner LM, Gelfand MJ, Laor T, Ryckman FC, Al-Ghawi H, Bove KE. A Welcome Surprise: Nodular Fasciitis Presenting as Soft Tissue Sarcoma. J Pediatr Hematol Oncol. 2010 Oct 21.
Taylor JA, Ryckman FC. Management of small bowel volvulus around feeding Roux-en-Y limbs. Pediatr Surg Int. 2010 Apr;26(4):439-42.
Ryckman FC, Yelton PA, Anneken AM, Kiessling PE, Schoettker PJ, Kotagal UR. Redesigning intensive care unit flow using variability management to improve access and safety. Jt Comm J Qual Patient Saf. 2009 Nov;35(11):535-43.
Rattan AS, Laor T, Ryckman FC, Brody AS. Pectus excavatum imaging: enough but not too much. Pediatr Radiol. 2010 Feb;40(2):168-72.
Propst EJ, Lin EP, Istaphanous GK, Boesch RP, Ryckman FC, Cotton RT, Rutter MJ. Management of traumatic tracheobronchial separation in a teenager using a fabricated extra-long endotracheal tube. Int J Pediatr Otorhinolaryngol. 2009 Aug;73(8):1163-7.
Ryckman FC, Schoettker PJ, Hays KR, Connelly BL, Blacklidge RL, Bedinghaus CA, Sorter ML, Friend LC, Kotagal UR. Reducing surgical site infections at a pediatric academic medical center. Jt Comm J Qual Patient Saf. 2009 Apr;35(4):192-8.
Dickie B, Dasgupta R, Nair R, Alonso MH, Ryckman FC, Tiao GM, Adams DM, Azizkhan RG. Spectrum of hepatic hemangiomas: management and outcome. J Pediatr Surg. 2009 Jan;44(1):125-33.
Sparling KW, Ryckman FC, Schoettker PJ, Byczkowski TL, Helpling A, Mandel K, Panchanathan A, Kotagal UR. Financial impact of failing to prevent surgical site infections. Qual Manag Health Care. 2007 Jul-Sep;16(3):219-25.
Nathan JD, Rudolph JA, Kocoshis SA, Alonso MH, Ryckman FC, Tiao GM. Isolated liver and multivisceral transplantation for total parenteral nutrition-related end-stage liver disease. J Pediatr Surg. 2007 Jan;42(1):143-7.
Aimen F. Shaaban, MD Director, Center for Fetal Cellular and Molecular Therapy
is a pediatric surgeon who leads a research program studying in utero transplantation. His laboratory seeks to better understand the manner in which immunologic tolerance develops in the fetus following transplantation in order to design less toxic and more effective therapies for the treatment of numerous diseases such as sickle cell disease, thalassemia, immunodeficiency, spinal muscular atrophy and inherited metabolic disorders.
Visit the Shaaban Lab.
Director, Center for Fetal Cellular and Molecular Therapy
Surgical treatment of fetal and newborn diseases including: open and minimally invasive fetal surgery; congenital lung and airway disease; congenital esophageal disease; sacrococcygeal teratoma; conjoined twins; neonatal surgery.
Examination of the mechanisms of long-term immunologic tolerance to prenatally transplanted stem cells; developmental hematology, pluripotent stem cell biology; fetal gene therapy
Dr. Shaaban served as an associate professor of surgery with tenure and as director of the Laboratory for Fetal Cellular Therapy at the University of Iowa Carver College of Medicine from 2008-2012. Prior to that he served as director of the Laboratory for Fetal Cellular Therapy at University of Wisconsin College of Medicine from 2002-2008.
MD: University of Illinois College of Medicine, Chicago, IL, 1991.
General Surgery Residency: University of Iowa Hospital and Clinics, Iowa City, Iowa, Jul 1991-Jun1996.
Pediatric Surgical Residency: The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, Jul 2000-Jun 2001.
Post-doctoral Fellowship in Fetal Surgery Research: Children's Institute for Surgical Science, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, Jul 1996-Jun 1999.
Certification: Diplomate of the National Board of Medical Examiners, 1991; diplomate of the American Board of Surgery, 1997, 2011; diplomate of the American Board of Pediatric Surgery, 2006.
Greg M. Tiao, MD Richard and Geralyn Azizkhan Chair in Pediatric Surgery
is a pediatric surgeon and a pediatric transplant surgeon who has his basic research in the care of children afflicted with biliary atresia.
Richard and Geralyn Azizkhan Chair in Pediatric Surgery
Surgical Director, Liver Transplantation
Associate Director, Pediatric Surgery Fellowship
As a pediatric surgeon and a transplant surgeon, Dr. Tiao is involved in the care of children afflicted with biliary atresia from the time of presentation and diagnosis to the initial Kasai portoenterostomy to the liver transplant, when necessary. He sees the many challenges children and their families experience when diagnosed with this life threatening disease process. From that perspective, defining the basis of this disease process such that therapeutic strategies can be developed eliminating these complex interventions is his career goal. His short term goal is to develop an independent research laboratory investigating the pathogenesis of virus induced biliary atresia specifically seeking to determine the mechanistic basis of this disease so that new treatment strategies can be developed to salvage the native liver.
Dr. Tiao's overarching hypothesis is that biliary atresia results from the infection of cholangiocytes by a virus triggering immune-mediated biliary obstruction. His focus is to determine the mechanisms used by RRV to infect cholangiocytes, how RRV undergoes replication within the cholangiocyte, and how infected cholangiocytes modify the microenvironment, activating the immune system resulting in biliary obstruction. Determination of the mechanistic basis of these inter-related events is essential to understanding the pathogenesis of virus induced BA. By focusing on the basis for the viral insult in the initiation of biliary atresia, he has defined an area of independence from Dr Jorge Bezerra, his primary research mentor.
BS: Northwestern University, Evanston, IL, 1986.
MD: University of Illinois, Chicago, IL, 1990.
Residency: Loyola University, Maywood, IL, 1991-1992; Senior Resident, Department of Surgery, University of Cincinnati, Cincinnati, OH, 1995-1997;Chief Resident, Department of Surgery, University of Cincinnati, Cincinnati, OH, 1997-1998.
Fellowships: Research Fellow, University of Cincinnati, Cincinnati, OH, 1992-1995; Transplant Surgery Fellow, University of Cincinnati, Cincinnati, OH, 2000-2002;Pediatric Surgery Fellow, Los Angeles Children's Hospital, Los Angeles, CA, 1998-2000.
Certification: Pediatric Surgeon, 2000; Transplant Surgeon, 2002.
Coots A, Donnelly B, Mohanty S, Tiao G. Rotavirus Infection of Human Cholangiocytes Parallels the Murine Model of Biliary Atresia. Journal of Surgical Research. Epub ahead of print. 2012.
Meyers RL, Tiao GM, Dunn SP, Langham Jr, MR. Liver transplantation in the management of unresectable hepatoblastoma in children. Frontiers in Bioscience. 2012 Jan;E4:1293-1302.
Shin CR, Nathan J, Alonso M, Yazigi N, Kocoshis S, Tiao G, Davies SM. Incidence of acute and chronic graft-versus-host disease and donor T-cell chimerism after small bowel or combined organ transplantation. J Pediatr Surg. 2011;46:1732-1738.
Fernandez KS, Baum R, Fung B, Yeager N, Leonis MA, Wagner LM, Tiao G, Ross ME. Chemoresistant Hepatoblastoma in a Patient with Mosaic Trisomy 18 Treated with Orthotopic Liver Transplantation. Peditr Blood Cancer. 2011;56:498-500.
Superina R, Magee J, Brandt M, Healey P, Tiao G, Ryckman F, Karrer F, Iyer K, Fecteau A, West K, Burns R, Flake A, Hammin L, Lowell J, Dillon P, Columbani P, Ricketts R, Yun L, Moore J, Kasper W. Childhood Liver Research and Education Network. AnnSurg. 2011.
Bondoc A, Taylor J, Alonso M, Nathan, J, Wang Y, Balistreri W, Bezerra J, Ryckman F, Tiao G. The Beneficial Impact of Revision of Kasai Portoenterostomy for Biliary Atresia: An Institutional Study. AnnSurg. 2012;255(3):570-6.
Wang W, Donnelly B, Bondoc A, Mohanty SK, McNeal M, Ward R, Sestak K, Zheng S, Tiao G. The rhesus rotavirus gene encoding VP4 is a major determinant in the pathogenesis of biliary atresia in newborn mice. J Virol. 2011 Jun.
Fernandez KS, Baum R, Fung B, Yeager N, Leonis MA, Wagner LM, Tiao G, Ross ME. Chemoresistant Hepatoblastoma in a Patient with Mosaic Trisomy 18 Treated with Orthotopic Liver Transplantation. Pediatr Blood Cancer. 2010;DOI 10.1002/pbc.22768.
Jafri M, Donnelly B, Bondoc A, Allen S, Tiao G. Cholangiocyte secretion of chemokines in experimental biliary atresia. J Pediatr Surg. 2009;44(3):500-7.
Bondoc AJ, Jafri MA, Donnelly B, Mohanty SK, McNeal MM, Ward, RL, Tiao GM. Prevention of the murine model of biliary atresia after live rotavirus vaccination of dams. J Pediatr Surg. 2009;44(8):1479-90.
The Molecular Determinants of Virus Induced Biliary Induced Biliary Asteria. Principal Investigator. Apr 2011 - Mar 2016.
Nycomed Liver Trial. Principal Investigator. 2012 - present. TC-2402-040-SP.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY: 1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2014 Cincinnati Children's Hospital Medical Center